nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCC10—Methotrexate—ankylosing spondylitis	0.103	0.125	CbGbCtD
Daunorubicin—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0733	0.0892	CbGbCtD
Daunorubicin—ABCB11—Dexamethasone—ankylosing spondylitis	0.0695	0.0847	CbGbCtD
Daunorubicin—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0695	0.0847	CbGbCtD
Daunorubicin—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0662	0.0806	CbGbCtD
Daunorubicin—ABCC1—Methotrexate—ankylosing spondylitis	0.0397	0.0483	CbGbCtD
Daunorubicin—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0367	0.0447	CbGbCtD
Daunorubicin—ABCC2—Dexamethasone—ankylosing spondylitis	0.0366	0.0445	CbGbCtD
Daunorubicin—ABCG2—Dexamethasone—ankylosing spondylitis	0.0331	0.0402	CbGbCtD
Daunorubicin—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0315	0.0384	CbGbCtD
Daunorubicin—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0305	0.0372	CbGbCtD
Daunorubicin—ABCC2—Methotrexate—ankylosing spondylitis	0.0294	0.0358	CbGbCtD
Daunorubicin—ABCG2—Methotrexate—ankylosing spondylitis	0.0266	0.0323	CbGbCtD
Daunorubicin—ABCB1—Betamethasone—ankylosing spondylitis	0.0205	0.0249	CbGbCtD
Daunorubicin—ABCB1—Prednisolone—ankylosing spondylitis	0.0202	0.0246	CbGbCtD
Daunorubicin—ABCB1—Prednisone—ankylosing spondylitis	0.0191	0.0232	CbGbCtD
Daunorubicin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0189	0.023	CbGbCtD
Daunorubicin—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0183	0.0223	CbGbCtD
Daunorubicin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0143	0.0174	CbGbCtD
Daunorubicin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0123	0.0149	CbGbCtD
Daunorubicin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0121	0.0147	CbGbCtD
Daunorubicin—ABCB1—Dexamethasone—ankylosing spondylitis	0.0119	0.0145	CbGbCtD
Daunorubicin—CYP3A4—Prednisone—ankylosing spondylitis	0.0114	0.0139	CbGbCtD
Daunorubicin—ABCB1—Methotrexate—ankylosing spondylitis	0.00958	0.0117	CbGbCtD
Daunorubicin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00714	0.0087	CbGbCtD
Daunorubicin—TOP2A—Methyltestosterone—Prednisone—ankylosing spondylitis	0.000466	0.506	CbGdCrCtD
Daunorubicin—TOP2A—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.000454	0.494	CbGdCrCtD
Daunorubicin—Erythema—Betamethasone—ankylosing spondylitis	0.000269	0.00151	CcSEcCtD
Daunorubicin—Erythema—Dexamethasone—ankylosing spondylitis	0.000269	0.00151	CcSEcCtD
Daunorubicin—Hallucination—Prednisone—ankylosing spondylitis	0.000268	0.00151	CcSEcCtD
Daunorubicin—Malaise—Triamcinolone—ankylosing spondylitis	0.000268	0.00151	CcSEcCtD
Daunorubicin—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000267	0.0015	CcSEcCtD
Daunorubicin—Malaise—Methylprednisolone—ankylosing spondylitis	0.000267	0.0015	CcSEcCtD
Daunorubicin—Syncope—Triamcinolone—ankylosing spondylitis	0.000266	0.0015	CcSEcCtD
Daunorubicin—Syncope—Methylprednisolone—ankylosing spondylitis	0.000265	0.00149	CcSEcCtD
Daunorubicin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000263	0.00148	CcSEcCtD
Daunorubicin—Oedema—Prednisolone—ankylosing spondylitis	0.000263	0.00148	CcSEcCtD
Daunorubicin—Dysuria—Methotrexate—ankylosing spondylitis	0.000263	0.00148	CcSEcCtD
Daunorubicin—Neutropenia—Methotrexate—ankylosing spondylitis	0.000263	0.00148	CcSEcCtD
Daunorubicin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000261	0.00147	CcSEcCtD
Daunorubicin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00026	0.00146	CcSEcCtD
Daunorubicin—Shock—Prednisolone—ankylosing spondylitis	0.000259	0.00146	CcSEcCtD
Daunorubicin—Cough—Triamcinolone—ankylosing spondylitis	0.000259	0.00146	CcSEcCtD
Daunorubicin—Convulsion—Triamcinolone—ankylosing spondylitis	0.000257	0.00145	CcSEcCtD
Daunorubicin—Tachycardia—Prednisolone—ankylosing spondylitis	0.000257	0.00145	CcSEcCtD
Daunorubicin—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000256	0.00144	CcSEcCtD
Daunorubicin—Hypertension—Triamcinolone—ankylosing spondylitis	0.000256	0.00144	CcSEcCtD
Daunorubicin—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000256	0.00144	CcSEcCtD
Daunorubicin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000255	0.00143	CcSEcCtD
Daunorubicin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000253	0.00142	CcSEcCtD
Daunorubicin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000252	0.00142	CcSEcCtD
Daunorubicin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000252	0.00142	CcSEcCtD
Daunorubicin—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000251	0.00141	CcSEcCtD
Daunorubicin—Depression—Methotrexate—ankylosing spondylitis	0.00025	0.00141	CcSEcCtD
Daunorubicin—Flushing—Prednisone—ankylosing spondylitis	0.00025	0.00141	CcSEcCtD
Daunorubicin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00025	0.00141	CcSEcCtD
Daunorubicin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00025	0.00141	CcSEcCtD
Daunorubicin—Discomfort—Triamcinolone—ankylosing spondylitis	0.00025	0.0014	CcSEcCtD
Daunorubicin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000249	0.0014	CcSEcCtD
Daunorubicin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000247	0.00139	CcSEcCtD
Daunorubicin—Renal failure—Methotrexate—ankylosing spondylitis	0.000246	0.00139	CcSEcCtD
Daunorubicin—Stomatitis—Methotrexate—ankylosing spondylitis	0.000244	0.00137	CcSEcCtD
Daunorubicin—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000244	0.00137	CcSEcCtD
Daunorubicin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000244	0.00137	CcSEcCtD
Daunorubicin—Malaise—Dexamethasone—ankylosing spondylitis	0.000243	0.00137	CcSEcCtD
Daunorubicin—Malaise—Betamethasone—ankylosing spondylitis	0.000243	0.00137	CcSEcCtD
Daunorubicin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000242	0.00136	CcSEcCtD
Daunorubicin—Oedema—Triamcinolone—ankylosing spondylitis	0.000242	0.00136	CcSEcCtD
Daunorubicin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000242	0.00136	CcSEcCtD
Daunorubicin—Syncope—Betamethasone—ankylosing spondylitis	0.000241	0.00136	CcSEcCtD
Daunorubicin—Syncope—Dexamethasone—ankylosing spondylitis	0.000241	0.00136	CcSEcCtD
Daunorubicin—Arrhythmia—Prednisone—ankylosing spondylitis	0.000241	0.00135	CcSEcCtD
Daunorubicin—Infection—Triamcinolone—ankylosing spondylitis	0.000241	0.00135	CcSEcCtD
Daunorubicin—Infection—Methylprednisolone—ankylosing spondylitis	0.00024	0.00135	CcSEcCtD
Daunorubicin—Shock—Triamcinolone—ankylosing spondylitis	0.000238	0.00134	CcSEcCtD
Daunorubicin—Insomnia—Prednisolone—ankylosing spondylitis	0.000238	0.00134	CcSEcCtD
Daunorubicin—Alopecia—Prednisone—ankylosing spondylitis	0.000238	0.00134	CcSEcCtD
Daunorubicin—Shock—Methylprednisolone—ankylosing spondylitis	0.000238	0.00134	CcSEcCtD
Daunorubicin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000237	0.00133	CcSEcCtD
Daunorubicin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000237	0.00133	CcSEcCtD
Daunorubicin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000236	0.00133	CcSEcCtD
Daunorubicin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000236	0.00133	CcSEcCtD
Daunorubicin—Erythema—Prednisone—ankylosing spondylitis	0.000234	0.00132	CcSEcCtD
Daunorubicin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000234	0.00132	CcSEcCtD
Daunorubicin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000234	0.00131	CcSEcCtD
Daunorubicin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000233	0.00131	CcSEcCtD
Daunorubicin—Convulsion—Betamethasone—ankylosing spondylitis	0.000233	0.00131	CcSEcCtD
Daunorubicin—Hypertension—Betamethasone—ankylosing spondylitis	0.000232	0.00131	CcSEcCtD
Daunorubicin—Hypertension—Dexamethasone—ankylosing spondylitis	0.000232	0.00131	CcSEcCtD
Daunorubicin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000229	0.00129	CcSEcCtD
Daunorubicin—Myalgia—Betamethasone—ankylosing spondylitis	0.000229	0.00129	CcSEcCtD
Daunorubicin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000228	0.00128	CcSEcCtD
Daunorubicin—Anxiety—Betamethasone—ankylosing spondylitis	0.000228	0.00128	CcSEcCtD
Daunorubicin—Discomfort—Betamethasone—ankylosing spondylitis	0.000226	0.00127	CcSEcCtD
Daunorubicin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000226	0.00127	CcSEcCtD
Daunorubicin—Pain—Prednisolone—ankylosing spondylitis	0.000225	0.00127	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000221	0.00124	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00022	0.00124	CcSEcCtD
Daunorubicin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00022	0.00124	CcSEcCtD
Daunorubicin—Oedema—Betamethasone—ankylosing spondylitis	0.00022	0.00124	CcSEcCtD
Daunorubicin—Oedema—Dexamethasone—ankylosing spondylitis	0.00022	0.00124	CcSEcCtD
Daunorubicin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00022	0.00124	CcSEcCtD
Daunorubicin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000219	0.00123	CcSEcCtD
Daunorubicin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000219	0.00123	CcSEcCtD
Daunorubicin—Infection—Dexamethasone—ankylosing spondylitis	0.000218	0.00123	CcSEcCtD
Daunorubicin—Infection—Betamethasone—ankylosing spondylitis	0.000218	0.00123	CcSEcCtD
Daunorubicin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000218	0.00122	CcSEcCtD
Daunorubicin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000217	0.00122	CcSEcCtD
Daunorubicin—Visual impairment—Methotrexate—ankylosing spondylitis	0.000217	0.00122	CcSEcCtD
Daunorubicin—Anaemia—Prednisone—ankylosing spondylitis	0.000217	0.00122	CcSEcCtD
Daunorubicin—Shock—Betamethasone—ankylosing spondylitis	0.000216	0.00122	CcSEcCtD
Daunorubicin—Shock—Dexamethasone—ankylosing spondylitis	0.000216	0.00122	CcSEcCtD
Daunorubicin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000216	0.00121	CcSEcCtD
Daunorubicin—Agitation—Prednisone—ankylosing spondylitis	0.000215	0.00121	CcSEcCtD
Daunorubicin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000215	0.00121	CcSEcCtD
Daunorubicin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000215	0.00121	CcSEcCtD
Daunorubicin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000214	0.00121	CcSEcCtD
Daunorubicin—Tachycardia—Betamethasone—ankylosing spondylitis	0.000214	0.00121	CcSEcCtD
Daunorubicin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000212	0.00119	CcSEcCtD
Daunorubicin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000212	0.00119	CcSEcCtD
Daunorubicin—Malaise—Prednisone—ankylosing spondylitis	0.000211	0.00119	CcSEcCtD
Daunorubicin—Syncope—Prednisone—ankylosing spondylitis	0.00021	0.00118	CcSEcCtD
Daunorubicin—Tinnitus—Methotrexate—ankylosing spondylitis	0.00021	0.00118	CcSEcCtD
Daunorubicin—Anorexia—Betamethasone—ankylosing spondylitis	0.000209	0.00118	CcSEcCtD
Daunorubicin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000209	0.00118	CcSEcCtD
Daunorubicin—Urticaria—Prednisolone—ankylosing spondylitis	0.000209	0.00118	CcSEcCtD
Daunorubicin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000209	0.00118	CcSEcCtD
Daunorubicin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000209	0.00117	CcSEcCtD
Daunorubicin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000208	0.00117	CcSEcCtD
Daunorubicin—Pain—Triamcinolone—ankylosing spondylitis	0.000207	0.00116	CcSEcCtD
Daunorubicin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000206	0.00116	CcSEcCtD
Daunorubicin—Convulsion—Prednisone—ankylosing spondylitis	0.000203	0.00114	CcSEcCtD
Daunorubicin—Hypertension—Prednisone—ankylosing spondylitis	0.000202	0.00114	CcSEcCtD
Daunorubicin—Chills—Methotrexate—ankylosing spondylitis	0.000202	0.00114	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.0002	0.00113	CcSEcCtD
Daunorubicin—Arthralgia—Prednisone—ankylosing spondylitis	0.0002	0.00112	CcSEcCtD
Daunorubicin—Myalgia—Prednisone—ankylosing spondylitis	0.0002	0.00112	CcSEcCtD
Daunorubicin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0002	0.00112	CcSEcCtD
Daunorubicin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000199	0.00112	CcSEcCtD
Daunorubicin—Anxiety—Prednisone—ankylosing spondylitis	0.000199	0.00112	CcSEcCtD
Daunorubicin—Alopecia—Methotrexate—ankylosing spondylitis	0.000199	0.00112	CcSEcCtD
Daunorubicin—Insomnia—Betamethasone—ankylosing spondylitis	0.000199	0.00112	CcSEcCtD
Daunorubicin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000199	0.00112	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000198	0.00111	CcSEcCtD
Daunorubicin—Discomfort—Prednisone—ankylosing spondylitis	0.000197	0.00111	CcSEcCtD
Daunorubicin—Erythema—Methotrexate—ankylosing spondylitis	0.000196	0.0011	CcSEcCtD
Daunorubicin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000194	0.00109	CcSEcCtD
Daunorubicin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000192	0.00108	CcSEcCtD
Daunorubicin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000192	0.00108	CcSEcCtD
Daunorubicin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000192	0.00108	CcSEcCtD
Daunorubicin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000191	0.00108	CcSEcCtD
Daunorubicin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000191	0.00108	CcSEcCtD
Daunorubicin—Oedema—Prednisone—ankylosing spondylitis	0.000191	0.00108	CcSEcCtD
Daunorubicin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000191	0.00107	CcSEcCtD
Daunorubicin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000191	0.00107	CcSEcCtD
Daunorubicin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000191	0.00107	CcSEcCtD
Daunorubicin—Infection—Prednisone—ankylosing spondylitis	0.00019	0.00107	CcSEcCtD
Daunorubicin—Back pain—Methotrexate—ankylosing spondylitis	0.00019	0.00107	CcSEcCtD
Daunorubicin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000189	0.00107	CcSEcCtD
Daunorubicin—Fatigue—Betamethasone—ankylosing spondylitis	0.000189	0.00107	CcSEcCtD
Daunorubicin—Shock—Prednisone—ankylosing spondylitis	0.000188	0.00106	CcSEcCtD
Daunorubicin—Pain—Betamethasone—ankylosing spondylitis	0.000188	0.00106	CcSEcCtD
Daunorubicin—Pain—Dexamethasone—ankylosing spondylitis	0.000188	0.00106	CcSEcCtD
Daunorubicin—Tachycardia—Prednisone—ankylosing spondylitis	0.000187	0.00105	CcSEcCtD
Daunorubicin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000185	0.00104	CcSEcCtD
Daunorubicin—Anorexia—Prednisone—ankylosing spondylitis	0.000182	0.00103	CcSEcCtD
Daunorubicin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000182	0.00102	CcSEcCtD
Daunorubicin—Anaemia—Methotrexate—ankylosing spondylitis	0.000181	0.00102	CcSEcCtD
Daunorubicin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000181	0.00102	CcSEcCtD
Daunorubicin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000181	0.00102	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00018	0.00101	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00018	0.00101	CcSEcCtD
Daunorubicin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000178	0.001	CcSEcCtD
Daunorubicin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000178	0.001	CcSEcCtD
Daunorubicin—Malaise—Methotrexate—ankylosing spondylitis	0.000177	0.000994	CcSEcCtD
Daunorubicin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000175	0.000987	CcSEcCtD
Daunorubicin—Urticaria—Betamethasone—ankylosing spondylitis	0.000175	0.000982	CcSEcCtD
Daunorubicin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000175	0.000982	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000174	0.000981	CcSEcCtD
Daunorubicin—Dizziness—Prednisolone—ankylosing spondylitis	0.000174	0.00098	CcSEcCtD
Daunorubicin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000174	0.000977	CcSEcCtD
Daunorubicin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000174	0.000977	CcSEcCtD
Daunorubicin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000174	0.000977	CcSEcCtD
Daunorubicin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000174	0.000977	CcSEcCtD
Daunorubicin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000174	0.000977	CcSEcCtD
Daunorubicin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000173	0.000975	CcSEcCtD
Daunorubicin—Insomnia—Prednisone—ankylosing spondylitis	0.000173	0.000974	CcSEcCtD
Daunorubicin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000171	0.000964	CcSEcCtD
Daunorubicin—Cough—Methotrexate—ankylosing spondylitis	0.000171	0.000962	CcSEcCtD
Daunorubicin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000171	0.000962	CcSEcCtD
Daunorubicin—Convulsion—Methotrexate—ankylosing spondylitis	0.00017	0.000955	CcSEcCtD
Daunorubicin—Chest pain—Methotrexate—ankylosing spondylitis	0.000167	0.000938	CcSEcCtD
Daunorubicin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000167	0.000938	CcSEcCtD
Daunorubicin—Myalgia—Methotrexate—ankylosing spondylitis	0.000167	0.000938	CcSEcCtD
Daunorubicin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000166	0.000936	CcSEcCtD
Daunorubicin—Rash—Prednisolone—ankylosing spondylitis	0.000166	0.000934	CcSEcCtD
Daunorubicin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000166	0.000933	CcSEcCtD
Daunorubicin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000165	0.00093	CcSEcCtD
Daunorubicin—Fatigue—Prednisone—ankylosing spondylitis	0.000165	0.000928	CcSEcCtD
Daunorubicin—Headache—Prednisolone—ankylosing spondylitis	0.000165	0.000928	CcSEcCtD
Daunorubicin—Discomfort—Methotrexate—ankylosing spondylitis	0.000165	0.000927	CcSEcCtD
Daunorubicin—Constipation—Prednisone—ankylosing spondylitis	0.000164	0.00092	CcSEcCtD
Daunorubicin—Confusional state—Methotrexate—ankylosing spondylitis	0.000161	0.000907	CcSEcCtD
Daunorubicin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00016	0.000901	CcSEcCtD
Daunorubicin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00016	0.0009	CcSEcCtD
Daunorubicin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00016	0.000899	CcSEcCtD
Daunorubicin—Infection—Methotrexate—ankylosing spondylitis	0.000159	0.000894	CcSEcCtD
Daunorubicin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000158	0.000887	CcSEcCtD
Daunorubicin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000158	0.000887	CcSEcCtD
Daunorubicin—Asthenia—Betamethasone—ankylosing spondylitis	0.000158	0.000887	CcSEcCtD
Daunorubicin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000157	0.000881	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000156	0.00088	CcSEcCtD
Daunorubicin—Nausea—Prednisolone—ankylosing spondylitis	0.000156	0.00088	CcSEcCtD
Daunorubicin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000155	0.000874	CcSEcCtD
Daunorubicin—Pruritus—Betamethasone—ankylosing spondylitis	0.000155	0.000874	CcSEcCtD
Daunorubicin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000155	0.00087	CcSEcCtD
Daunorubicin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000154	0.000866	CcSEcCtD
Daunorubicin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000154	0.000864	CcSEcCtD
Daunorubicin—Rash—Triamcinolone—ankylosing spondylitis	0.000153	0.000859	CcSEcCtD
Daunorubicin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000153	0.000858	CcSEcCtD
Daunorubicin—Anorexia—Methotrexate—ankylosing spondylitis	0.000152	0.000858	CcSEcCtD
Daunorubicin—Rash—Methylprednisolone—ankylosing spondylitis	0.000152	0.000857	CcSEcCtD
Daunorubicin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000152	0.000856	CcSEcCtD
Daunorubicin—Urticaria—Prednisone—ankylosing spondylitis	0.000152	0.000855	CcSEcCtD
Daunorubicin—Headache—Triamcinolone—ankylosing spondylitis	0.000152	0.000853	CcSEcCtD
Daunorubicin—Headache—Methylprednisolone—ankylosing spondylitis	0.000151	0.000851	CcSEcCtD
Daunorubicin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000151	0.000851	CcSEcCtD
Daunorubicin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000151	0.000851	CcSEcCtD
Daunorubicin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00015	0.000846	CcSEcCtD
Daunorubicin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00015	0.000846	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000146	0.00082	CcSEcCtD
Daunorubicin—Dizziness—Betamethasone—ankylosing spondylitis	0.000145	0.000817	CcSEcCtD
Daunorubicin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000145	0.000817	CcSEcCtD
Daunorubicin—Insomnia—Methotrexate—ankylosing spondylitis	0.000145	0.000814	CcSEcCtD
Daunorubicin—Nausea—Triamcinolone—ankylosing spondylitis	0.000144	0.000809	CcSEcCtD
Daunorubicin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000144	0.000807	CcSEcCtD
Daunorubicin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000143	0.000802	CcSEcCtD
Daunorubicin—Somnolence—Methotrexate—ankylosing spondylitis	0.000142	0.0008	CcSEcCtD
Daunorubicin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000141	0.000793	CcSEcCtD
Daunorubicin—Vomiting—Betamethasone—ankylosing spondylitis	0.00014	0.000786	CcSEcCtD
Daunorubicin—Vomiting—Dexamethasone—ankylosing spondylitis	0.00014	0.000786	CcSEcCtD
Daunorubicin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000139	0.000782	CcSEcCtD
Daunorubicin—Rash—Dexamethasone—ankylosing spondylitis	0.000139	0.000779	CcSEcCtD
Daunorubicin—Rash—Betamethasone—ankylosing spondylitis	0.000139	0.000779	CcSEcCtD
Daunorubicin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000138	0.000779	CcSEcCtD
Daunorubicin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000138	0.000779	CcSEcCtD
Daunorubicin—Fatigue—Methotrexate—ankylosing spondylitis	0.000138	0.000776	CcSEcCtD
Daunorubicin—Headache—Betamethasone—ankylosing spondylitis	0.000138	0.000774	CcSEcCtD
Daunorubicin—Headache—Dexamethasone—ankylosing spondylitis	0.000138	0.000774	CcSEcCtD
Daunorubicin—Asthenia—Prednisone—ankylosing spondylitis	0.000137	0.000772	CcSEcCtD
Daunorubicin—Pain—Methotrexate—ankylosing spondylitis	0.000137	0.000769	CcSEcCtD
Daunorubicin—Pruritus—Prednisone—ankylosing spondylitis	0.000135	0.000762	CcSEcCtD
Daunorubicin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000132	0.000741	CcSEcCtD
Daunorubicin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000131	0.000736	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000131	0.000736	CcSEcCtD
Daunorubicin—Nausea—Dexamethasone—ankylosing spondylitis	0.000131	0.000734	CcSEcCtD
Daunorubicin—Nausea—Betamethasone—ankylosing spondylitis	0.000131	0.000734	CcSEcCtD
Daunorubicin—Urticaria—Methotrexate—ankylosing spondylitis	0.000127	0.000715	CcSEcCtD
Daunorubicin—Dizziness—Prednisone—ankylosing spondylitis	0.000127	0.000712	CcSEcCtD
Daunorubicin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000126	0.000711	CcSEcCtD
Daunorubicin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000126	0.000711	CcSEcCtD
Daunorubicin—Vomiting—Prednisone—ankylosing spondylitis	0.000122	0.000684	CcSEcCtD
Daunorubicin—Rash—Prednisone—ankylosing spondylitis	0.000121	0.000679	CcSEcCtD
Daunorubicin—Dermatitis—Prednisone—ankylosing spondylitis	0.000121	0.000678	CcSEcCtD
Daunorubicin—Headache—Prednisone—ankylosing spondylitis	0.00012	0.000674	CcSEcCtD
Daunorubicin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000118	0.000663	CcSEcCtD
Daunorubicin—Asthenia—Methotrexate—ankylosing spondylitis	0.000115	0.000645	CcSEcCtD
Daunorubicin—Nausea—Prednisone—ankylosing spondylitis	0.000114	0.000639	CcSEcCtD
Daunorubicin—Pruritus—Methotrexate—ankylosing spondylitis	0.000113	0.000636	CcSEcCtD
Daunorubicin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000109	0.000616	CcSEcCtD
Daunorubicin—Dizziness—Methotrexate—ankylosing spondylitis	0.000106	0.000595	CcSEcCtD
Daunorubicin—Vomiting—Methotrexate—ankylosing spondylitis	0.000102	0.000572	CcSEcCtD
Daunorubicin—Rash—Methotrexate—ankylosing spondylitis	0.000101	0.000567	CcSEcCtD
Daunorubicin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000101	0.000567	CcSEcCtD
Daunorubicin—Headache—Methotrexate—ankylosing spondylitis	0.0001	0.000564	CcSEcCtD
Daunorubicin—Nausea—Methotrexate—ankylosing spondylitis	9.5e-05	0.000534	CcSEcCtD
